• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于刃天青的A549细胞系活力测定标准化方案,以提高细胞毒性数据的可靠性。

Standardized Protocol for Resazurin-Based Viability Assays on A549 Cell Line for Improving Cytotoxicity Data Reliability.

作者信息

Petiti Jessica, Caria Sabrina, Revel Laura, Pegoraro Mattia, Divieto Carla

机构信息

Division of Advanced Materials Metrology and Life Sciences, Istituto Nazionale di Ricerca Metrologica (INRIM), 10135 Turin, Italy.

Department of Chemistry, University of Turin, 10125 Turin, Italy.

出版信息

Cells. 2024 Nov 26;13(23):1959. doi: 10.3390/cells13231959.

DOI:10.3390/cells13231959
PMID:39682708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11640476/
Abstract

The A549 cell line has become a cornerstone in biomedical research, particularly in cancer studies and serves as a critical tool in cytotoxicity studies and drug screening where it is used to evaluate the impact of pharmaceutical compounds on cellular viability. One of the most widely adopted methods for viability assessment, which is also used in evaluating drug cytotoxicity, is the resazurin-based assay. This assay exploits the ability of living cells to convert resazurin into fluorescent resorufin, providing a reliable indicator of metabolic activity. By measuring this conversion, cell viability can be estimated. Resazurin assay is extensively used for evaluating cytotoxic effects on various cell lines, including A549 cells, thereby bridging the gap between in vitro experimentation and drug development. However, frequent data inconsistencies in pre-clinical drug screening highlight the critical need for standardization to ensure reliability and reproducibility. This manuscript addresses these challenges by describing the optimization of resazurin-based viability assays for A549 cells in both 2D cultures and 3D fibrin gel models. By optimizing this test, the study aims to enhance the reliability of cytotoxicity results and introduces a new standard operating procedure, thus providing consistent results with minimal measurement uncertainty. This standardization is crucial for advancing drug screening and ensuring robust research findings.

摘要

A549细胞系已成为生物医学研究的基石,尤其是在癌症研究中,并作为细胞毒性研究和药物筛选的关键工具,用于评估药物化合物对细胞活力的影响。基于刃天青的检测法是评估细胞活力最广泛采用的方法之一,也用于评估药物细胞毒性。该检测法利用活细胞将刃天青转化为荧光试卤灵的能力,提供代谢活性的可靠指标。通过测量这种转化,可以估计细胞活力。刃天青检测法广泛用于评估对包括A549细胞在内的各种细胞系的细胞毒性作用,从而弥合体外实验与药物开发之间的差距。然而,临床前药物筛选中频繁的数据不一致突出了标准化的迫切需求,以确保可靠性和可重复性。本手稿通过描述在二维培养和三维纤维蛋白凝胶模型中对A549细胞基于刃天青的活力检测法的优化来解决这些挑战。通过优化该检测,本研究旨在提高细胞毒性结果的可靠性,并引入新的标准操作规程,从而以最小的测量不确定性提供一致的结果。这种标准化对于推进药物筛选和确保可靠的研究结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/8c2452c8c6d8/cells-13-01959-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/b77506fec637/cells-13-01959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/a554cd681fcb/cells-13-01959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/c97764467e7d/cells-13-01959-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/0d9e48fc56e5/cells-13-01959-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/964b6cb60ac7/cells-13-01959-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/8c2452c8c6d8/cells-13-01959-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/b77506fec637/cells-13-01959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/a554cd681fcb/cells-13-01959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/c97764467e7d/cells-13-01959-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/0d9e48fc56e5/cells-13-01959-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/964b6cb60ac7/cells-13-01959-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/11640476/8c2452c8c6d8/cells-13-01959-g006.jpg

相似文献

1
Standardized Protocol for Resazurin-Based Viability Assays on A549 Cell Line for Improving Cytotoxicity Data Reliability.基于刃天青的A549细胞系活力测定标准化方案,以提高细胞毒性数据的可靠性。
Cells. 2024 Nov 26;13(23):1959. doi: 10.3390/cells13231959.
2
Standard Operating Procedure to Optimize Resazurin-Based Viability Assays.优化基于 Resazurin 的细胞活力检测的标准操作规程。
Biosensors (Basel). 2024 Mar 26;14(4):156. doi: 10.3390/bios14040156.
3
The Resazurin Reduction Assay Can Distinguish Cytotoxic from Cytostatic Compounds in Spheroid Screening Assays.刃天青还原试验可在球体筛选试验中区分细胞毒性化合物和细胞生长抑制化合物。
J Biomol Screen. 2014 Aug;19(7):1047-59. doi: 10.1177/1087057114532352. Epub 2014 Apr 23.
4
Resazurin Live Cell Assay: Setup and Fine-Tuning for Reliable Cytotoxicity Results.刃天青活细胞检测:为获得可靠的细胞毒性结果进行设置与微调
Methods Mol Biol. 2017;1647:207-219. doi: 10.1007/978-1-4939-7201-2_14.
5
Non-specific interaction of carbon nanotubes with the resazurin assay reagent: impact on in vitro assessment of nanoparticle cytotoxicity.碳纳米管与刃天青检测试剂的非特异性相互作用:对纳米颗粒细胞毒性体外评估的影响
Toxicol In Vitro. 2015 Feb;29(1):142-7. doi: 10.1016/j.tiv.2014.09.009. Epub 2014 Oct 2.
6
An improved resazurin-based cytotoxicity assay for hepatic cells.一种改良的基于刃天青的肝细胞细胞毒性测定法。
Cell Biol Toxicol. 2002;18(3):157-73. doi: 10.1023/a:1015559603643.
7
Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon.重新审视基于刃天青的细胞活力检测:拓展应用范围
Biosensors (Basel). 2022 Mar 25;12(4):196. doi: 10.3390/bios12040196.
8
Drug Screening by Resazurin Colorimetry in Ewing Sarcoma.Resazurin 比色法在尤文肉瘤中的药物筛选。
Methods Mol Biol. 2021;2226:159-166. doi: 10.1007/978-1-0716-1020-6_12.
9
Resazurin-Based Assay to Evaluate Cell Viability After Quantum Dot Interaction.基于 Resazurin 的检测法用于评估量子点相互作用后的细胞活力。
Methods Mol Biol. 2020;2135:213-221. doi: 10.1007/978-1-0716-0463-2_12.
10
Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status.Resazurin 还原法检测的再探讨:准确报告代谢状态相对差异的指南。
Molecules. 2023 Mar 1;28(5):2283. doi: 10.3390/molecules28052283.

引用本文的文献

1
Gold Nanoparticles Disrupt Mitochondrial Activity in Hypothalamic POMC Cells: Implications for Energy Homeostasis.金纳米颗粒破坏下丘脑POMC细胞中的线粒体活性:对能量稳态的影响。
Nanomaterials (Basel). 2025 Aug 21;15(16):1291. doi: 10.3390/nano15161291.
2
Enhanced Antifungal Efficacy through Controlled Delivery of Amphotericin B Loaded in Polyetheramine-Epoxide Nanogels.通过聚醚胺 - 环氧化物纳米凝胶控制递送两性霉素B增强抗真菌疗效
ACS Polym Au. 2025 Jul 25;5(4):406-419. doi: 10.1021/acspolymersau.5c00037. eCollection 2025 Aug 13.
3
Aβ Improves Cerebrovascular Endothelial Function via NOX4-Dependent Hydrogen Peroxide Release.

本文引用的文献

1
The Role of Quality Assurance in Clinical Trials: Safeguarding Data Integrity and Compliance.质量保证在临床试验中的作用:保障数据完整性与合规性。
Cureus. 2024 Aug 23;16(8):e67573. doi: 10.7759/cureus.67573. eCollection 2024 Aug.
2
Standard Operating Procedure to Optimize Resazurin-Based Viability Assays.优化基于 Resazurin 的细胞活力检测的标准操作规程。
Biosensors (Basel). 2024 Mar 26;14(4):156. doi: 10.3390/bios14040156.
3
Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma.
淀粉样β蛋白通过依赖于NOX4的过氧化氢释放改善脑血管内皮功能。
Int J Mol Sci. 2025 Jul 15;26(14):6759. doi: 10.3390/ijms26146759.
4
Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability.优化基于刃天青的P-MSC/TER308细胞系活力测定方法以提高结果可靠性。
BMC Res Notes. 2025 May 22;18(1):228. doi: 10.1186/s13104-025-07298-w.
5
Application of an Integrated Single-Cell and Three-Dimensional Spheroid Culture Platform for Investigating Drug Resistance Heterogeneity and Epithelial-Mesenchymal Transition (EMT) in Lung Cancer Subclones.一种整合的单细胞和三维球体培养平台在研究肺癌亚克隆中的耐药异质性和上皮-间质转化(EMT)中的应用
Int J Mol Sci. 2025 Feb 19;26(4):1766. doi: 10.3390/ijms26041766.
基于药物重定位发现治疗肺腺癌的药物靶点和治疗药物。
Biomed Pharmacother. 2023 May;161:114486. doi: 10.1016/j.biopha.2023.114486. Epub 2023 Mar 10.
4
Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status.Resazurin 还原法检测的再探讨:准确报告代谢状态相对差异的指南。
Molecules. 2023 Mar 1;28(5):2283. doi: 10.3390/molecules28052283.
5
Recommendations for robust and reproducible preclinical research in personalised medicine.个性化医学中稳健且可重复的临床前研究建议。
BMC Med. 2023 Jan 8;21(1):14. doi: 10.1186/s12916-022-02719-0.
6
Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon.重新审视基于刃天青的细胞活力检测:拓展应用范围
Biosensors (Basel). 2022 Mar 25;12(4):196. doi: 10.3390/bios12040196.
7
Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles.载银纳米粒子涂层的三种新型配合物对 A549 癌细胞的抗肿瘤活性。
Int J Mol Sci. 2022 Mar 10;23(6):2980. doi: 10.3390/ijms23062980.
8
Between two stools: preclinical research, reproducibility, and statistical design of experiments.左右为难:临床前研究、可重复性和实验的统计设计。
BMC Res Notes. 2022 Feb 21;15(1):73. doi: 10.1186/s13104-022-05965-w.
9
A framework for clinical and translational research in the era of rigor and reproducibility.严谨性和可重复性时代的临床与转化研究框架。
J Clin Transl Sci. 2020 Aug 19;5(1):e31. doi: 10.1017/cts.2020.523.
10
Repurposing A549 Adenocarcinoma Cells: New Options for Drug Discovery.重新利用A549腺癌细胞:药物发现的新选择。
Am J Respir Cell Mol Biol. 2021 Apr;64(4):405-406. doi: 10.1165/rcmb.2021-0048ED.